Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Australia
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Celexa
2. Citalopram
3. Cytalopram
4. Lu-10-171
5. Lu10171
6. Seropram
1. 59729-32-7
2. Citalopram Hbr
3. Celexa
4. Cipramil
5. 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile Hydrobromide
6. Elopram
7. Seropram
8. Bonitrile Hbr
9. Nitalapram Hbr
10. Lu 10-171-b
11. Citalopram (hydrobromide)
12. Citalopram, Hydrobromide Salt
13. Lu 10-171 Hbr
14. 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3h-2-benzofuran-5-carbonitrile;hydrobromide
15. Nsc-758684
16. Citalopram (as Hydrobromide)
17. 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile Hydrobromide
18. I1e9d14f36
19. Cipram
20. (s)-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile Hydrobromide
21. Lu 10-171
22. Lu-10-171-b
23. Citalopram D4 Hbr
24. 59729-32-7 (hbr)
25. 1-(3-(dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile Monohydrobromide
26. 5-isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-, Monohydrobromide
27. Prepram Hbr
28. 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile Hydrobromide
29. Smr000326936
30. Citalopram Hydrobromide [usan]
31. Lu-10-171
32. Sr-01000003129
33. 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile Monohydrobromide
34. Einecs 261-890-6
35. C20h21fn2o.hbr
36. Apertia
37. Prisdal
38. Lupram
39. Sepram
40. Unii-i1e9d14f36
41. 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile Hydrobromide
42. Citalopram Hydrobromide [usan:usp]
43. Celexa (tn)
44. Mfcd02101306
45. Cpd000326936
46. Schembl1118
47. Mls000758293
48. Mls000860078
49. Mls001401376
50. Mls002222294
51. Citalopram Hydrobromide (usp)
52. Citalopram Hydrobromide Solution
53. Chembl1200781
54. Dtxsid40872344
55. Pharmakon1600-01504172
56. Citalopram Hydrogen Bromide- Bio-x
57. Hy-b1287
58. Lu-10-171b
59. Citalopram Hydrobromide [mi]
60. Tox21_500258
61. Nsc758684
62. S4749
63. Zd 211
64. Zd-211
65. Citalopram Hydrobromide [hsdb]
66. Akos005145738
67. Ab10921
68. Ac-1595
69. Bcp9000537
70. Ccg-101022
71. Ccg-213271
72. Citalopram Hydrobromide [mart.]
73. Citalopram Hydrobromide [vandf]
74. Cs-4735
75. Ks-1043
76. Lp00258
77. Nc00272
78. Nsc 758684
79. Citalopram Hydrobromide [usp-rs]
80. Citalopram Hydrobromide [who-dd]
81. Ncgc00093717-01
82. Ncgc00093717-02
83. Ncgc00093717-03
84. Ncgc00260943-01
85. Bc164316
86. Citalopram Hydrobromide, >=98% (hplc)
87. Citalopram Hydrobromide [orange Book]
88. Eu-0100258
89. Ft-0600173
90. Citalopram Hydrobromide [ep Monograph]
91. Citalopram Hydrobromide [usp Impurity]
92. C 7861
93. C75790
94. Citalopram Hydrobromide [usp Monograph]
95. D00822
96. 729c327
97. A832439
98. Q-200865
99. Sr-01000003129-2
100. Sr-01000003129-4
101. W-105304
102. Citalopram Hydrobromide 100 Microg/ml In Acetonitrile
103. Q27280253
104. Sr-01000003129-10
105. Z1550648760
106. Citalopram Hydrobromide 0.1 Mg/ml In Methanol (as Free Base)
107. Citalopram Hydrobromide 1.0 Mg/ml In Methanol (as Free Base)
108. Citalopram Hydrobromide, European Pharmacopoeia (ep) Reference Standard
109. Citalopram Hydrobromide, United States Pharmacopeia (usp) Reference Standard
110. 1-(3-(dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile Monohbr
111. Citalopram For System Suitability, European Pharmacopoeia (ep) Reference Standard
112. Citalopram Hydrobromide, Pharmaceutical Secondary Standard; Certified Reference Material
113. 1-(3-dimethylamino-propyl)-1-(4-fluoro-phenyl)-1,3-dihydro-isobenzofuran-5-carbonitrile Hydrobromide
114. 1-(3-dimethylaminopropyl)-1-(4'-fluorophenyl)-1, 3-dihydroisobenzofuran-5-carbonitrile Hbr
115. 1-(3-dimethylaminopropyl)-1-(4'-fluorophenyl)-1, 3-dihydroisobenzofuran-5-carbonitrile Hydrobromide
116. 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitril E Hydrobromide
117. 5-isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-, Monohbr
118. 5-isobenzofurancarbonitrile, 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-, Hydrobromide (1:1)
119. Citalopram Hydrobromide Solution, 1.0 Mg/ml In Methanol (as Free Base), Ampule Of 1 Ml, Certified Reference Material
120. Citalopram Hydrobromide Solution, 100 Mug/ml In Methanol (as Free Base), Ampule Of 1 Ml, Certified Reference Material
Molecular Weight | 405.3 g/mol |
---|---|
Molecular Formula | C20H22BrFN2O |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 5 |
Exact Mass | 404.08995 g/mol |
Monoisotopic Mass | 404.08995 g/mol |
Topological Polar Surface Area | 36.3 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 466 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Celexa |
Active Ingredient | Citalopram hydrobromide |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 40mg base; eq 20mg base; eq 10mg base |
Market Status | Prescription |
Company | Forest Labs |
2 of 4 | |
---|---|
Drug Name | Citalopram hydrobromide |
PubMed Health | Citalopram (By mouth) |
Drug Classes | Antidepressant |
Active Ingredient | Citalopram hydrobromide |
Dosage Form | Tablet; Capsule; Solution |
Route | orally disintegrating; Oral |
Strength | eq 40mg base; eq 10mg base/5ml; eq 20mg base; eq 10mg base; 40mg |
Market Status | Prescription |
Company | Mylan Pharms; Glenmark Generics; Silarx; Amneal Pharms Ny; Teva Pharms; Epic Pharma; Apotex; Aurobindo; Aurobindo Pharma; Sun Pharm Inds; Torrent Pharms; Dr Reddys Labs; Pliva; Invagen Pharms; Cipla; Mylan; Roxane; Biovail Labs Intl |
3 of 4 | |
---|---|
Drug Name | Celexa |
Active Ingredient | Citalopram hydrobromide |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 40mg base; eq 20mg base; eq 10mg base |
Market Status | Prescription |
Company | Forest Labs |
4 of 4 | |
---|---|
Drug Name | Citalopram hydrobromide |
PubMed Health | Citalopram (By mouth) |
Drug Classes | Antidepressant |
Active Ingredient | Citalopram hydrobromide |
Dosage Form | Tablet; Capsule; Solution |
Route | orally disintegrating; Oral |
Strength | eq 40mg base; eq 10mg base/5ml; eq 20mg base; eq 10mg base; 40mg |
Market Status | Prescription |
Company | Mylan Pharms; Glenmark Generics; Silarx; Amneal Pharms Ny; Teva Pharms; Epic Pharma; Apotex; Aurobindo; Aurobindo Pharma; Sun Pharm Inds; Torrent Pharms; Dr Reddys Labs; Pliva; Invagen Pharms; Cipla; Mylan; Roxane; Biovail Labs Intl |
Selective Serotonin Reuptake Inhibitors
Compounds that specifically inhibit the reuptake of serotonin in the brain. (See all compounds classified as Selective Serotonin Reuptake Inhibitors.)
Antidepressive Agents, Second-Generation
A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake. (See all compounds classified as Antidepressive Agents, Second-Generation.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Citalopram Hydrobromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Citalopram Hydrobromide, including repackagers and relabelers. The FDA regulates Citalopram Hydrobromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Citalopram Hydrobromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Citalopram Hydrobromide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Citalopram Hydrobromide supplier is an individual or a company that provides Citalopram Hydrobromide active pharmaceutical ingredient (API) or Citalopram Hydrobromide finished formulations upon request. The Citalopram Hydrobromide suppliers may include Citalopram Hydrobromide API manufacturers, exporters, distributors and traders.
click here to find a list of Citalopram Hydrobromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Citalopram Hydrobromide DMF (Drug Master File) is a document detailing the whole manufacturing process of Citalopram Hydrobromide active pharmaceutical ingredient (API) in detail. Different forms of Citalopram Hydrobromide DMFs exist exist since differing nations have different regulations, such as Citalopram Hydrobromide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Citalopram Hydrobromide DMF submitted to regulatory agencies in the US is known as a USDMF. Citalopram Hydrobromide USDMF includes data on Citalopram Hydrobromide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Citalopram Hydrobromide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Citalopram Hydrobromide suppliers with USDMF on PharmaCompass.
A Citalopram Hydrobromide CEP of the European Pharmacopoeia monograph is often referred to as a Citalopram Hydrobromide Certificate of Suitability (COS). The purpose of a Citalopram Hydrobromide CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Citalopram Hydrobromide EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Citalopram Hydrobromide to their clients by showing that a Citalopram Hydrobromide CEP has been issued for it. The manufacturer submits a Citalopram Hydrobromide CEP (COS) as part of the market authorization procedure, and it takes on the role of a Citalopram Hydrobromide CEP holder for the record. Additionally, the data presented in the Citalopram Hydrobromide CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Citalopram Hydrobromide DMF.
A Citalopram Hydrobromide CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Citalopram Hydrobromide CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Citalopram Hydrobromide suppliers with CEP (COS) on PharmaCompass.
A Citalopram Hydrobromide written confirmation (Citalopram Hydrobromide WC) is an official document issued by a regulatory agency to a Citalopram Hydrobromide manufacturer, verifying that the manufacturing facility of a Citalopram Hydrobromide active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Citalopram Hydrobromide APIs or Citalopram Hydrobromide finished pharmaceutical products to another nation, regulatory agencies frequently require a Citalopram Hydrobromide WC (written confirmation) as part of the regulatory process.
click here to find a list of Citalopram Hydrobromide suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Citalopram Hydrobromide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Citalopram Hydrobromide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Citalopram Hydrobromide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Citalopram Hydrobromide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Citalopram Hydrobromide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Citalopram Hydrobromide suppliers with NDC on PharmaCompass.
Citalopram Hydrobromide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Citalopram Hydrobromide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Citalopram Hydrobromide GMP manufacturer or Citalopram Hydrobromide GMP API supplier for your needs.
A Citalopram Hydrobromide CoA (Certificate of Analysis) is a formal document that attests to Citalopram Hydrobromide's compliance with Citalopram Hydrobromide specifications and serves as a tool for batch-level quality control.
Citalopram Hydrobromide CoA mostly includes findings from lab analyses of a specific batch. For each Citalopram Hydrobromide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Citalopram Hydrobromide may be tested according to a variety of international standards, such as European Pharmacopoeia (Citalopram Hydrobromide EP), Citalopram Hydrobromide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Citalopram Hydrobromide USP).
LOOKING FOR A SUPPLIER?